Search results for: 'counter industry forecasts'

11 Jun 2024  |  Global  |  Market Research

Global Sports Medicine Industry, Forecast to 2028

Medical Advancements in Treating, Diagnosing, and Preventing Injuries Creates Growth Opportunities

Infographics

×

This Frost & Sullivan analysis covers innovative devices propelling industry growth as well as market trends and emerging business models that will dominate the sports medicine sector. It highlights the dominating solutions in the sports medicine devices industry, including body reconstruction and body support and recovery devices, as well as compa...

An increasing focus on biologics, genomics, and multi-omics; the adoption of digital technologies; and a shift to patient-centric models are transforming the life sciences industry. At the same time, the emergence of value-based models, R&D activities to treat complex diseases, and healthcare consumerism provide an impetus to precision medicine. Wi...

In this analysis, Frost & Sullivan identifies and defines the leading trends shaping the global pharmaceutical landscape. The study period is 2022–2030, with 2024 as the base year and 2025–2028 as the forecast period. The geographic scope includes 5 regions: North America, Latin America (LATAM) and the Caribbean, Asia-Pacific (APAC), Europe, and th...

This Frost & Sullivan annual outlook analyzes the medical devices industry across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. The study provides insights into market size, growth rates, opportunities, strategic imperatives, and macroeconomic trends shaping the medical devices industry. The study period spans 202...

05 Apr 2023  |  Asia Pacific  |  Market Outlook

Asia-Pacific Pharmaceutical Industry Outlook, 2023

Disruptive Technology Adoption and Outsourcing Growth is Advancing Innovation in the Pharmaceutical Industry

Infographics

×

Asia-Pacific’s pharmaceutical market is forecast to record 4.2% growth from 2022 to 2027, with China and Japan dominating the market in terms of value. Generics dominate the regional markets based on volume, directly impacting innovator molecule uptake. Nevertheless, Asia-Pacific is establishing itself as a global innovation hub, with China, Japan,...

This outlook identifies the trends shaping the global pharmaceutical landscape. The growth of the global pharmaceutical industry will plateau in 2023 due to a slowdown of the biologics segment as a result of a decrease in the uptake of COVID-19 vaccines and therapeutics. Market growth will be low in the United States and Europe and highest in the A...

Research Scope: Economy, Industry Geographic Scope: Sri Lanka Industry Scope: Medical Tourism, Healthcare, Tourism Disparity in healthcare costs between developed and emerging countries, coupled with advanced healthcare infrastructure in emerging economies is helping to drive medical tourism in emerging countries. Sri Lanka is amongst the emergi...

This market insight provides data for the Global Opioid Therapeutics market. The analysis looks at opioid pharmaceutical pipeline drugs currently in the market and drugs that are in Phase III stage, which pose a potential threat to competitors. It also offers a competitive analysis of the drugs, and the forecast outcome and impact of each of these ...

The global pharmaceutical market is projected to reach approximately $1.72 trillion in 2026, with large molecules driving most incremental growth while small molecules remain the sector’s cash flow base. The current growth cycle concentrates on cardiometabolic and oncology, led by GLP-1 platforms and antibody–drug conjugates (ADCs). Competitive adv...